Page last updated: 2024-08-24

valsartan and Pregnancy

valsartan has been researched along with Pregnancy in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's8 (61.54)29.6817
2010's3 (23.08)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Daly, S; McGrath, A; O'Connor, E; Petch, S1
Asada, N; Awazu, M; Furuhata, M; Hashiguchi, A; Matsuoka, D; Naganuma, K; Noda, S; Tsukahara, T1
Brown, NJ; Hubers, SA1
Friedrich, D; Gortner, L; Herkenrath, P; Hoppe, B; Hünseler, C; Kattner, E; Körber, F; Lindner, U; Müller, A; Oberthuer, A; Paneitz, A; Roth, B; Schaible, T; Schmitt, K; Welzing, L1
Biswas, PN; Shakir, SW; Wilton, LV1
Berkane, N; Carlier, P; Heim, N; Mathieu, E; Uzan, S; Verstraete, L1
Bos-Thompson, MA; Boulot, P; Dechaud, H; Hillaire-Buys, D; Mazurier, E; Morin, D; Muller, F1
Ripley, TL1
Chappell, MC; Ferrario, CM; Gallagher, PE; Tallant, EA1
Madelenat, P; Mahieu-Caputo, D; Popovic, I; Roger, N1
Beevers, DG; Beevers, M; Chung, NA; Lip, GY1
Benachi, A; Daikha-Dahmane, F; Gubler, MC; Laurent, N; Martinovic, J1

Reviews

4 review(s) available for valsartan and Pregnancy

ArticleYear
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Circulation, 2016, Mar-15, Volume: 133, Issue:11

    Topics: Abnormalities, Drug-Induced; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Bradykinin; Contraindications; Drug Combinations; Drug Costs; Drug Synergism; Enalapril; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Failure; Humans; Hyperkalemia; Hypertension; Kidney; Multicenter Studies as Topic; Natriuretic Peptides; Neprilysin; Pregnancy; Prodrugs; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Stroke Volume; Tetrazoles; Thiazepines; Valsartan

2016
Fetal toxicity of valsartan and possible reversible adverse side effects.
    Birth defects research. Part A, Clinical and molecular teratology, 2004, Volume: 70, Issue:8

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hypertension; Kidney; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Tetrazoles; Ultrasonography; Valine; Valsartan

2004
Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1

    Topics: Amniotic Fluid; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; beta 2-Microglobulin; Child, Preschool; Female; Follow-Up Studies; Gestational Age; Humans; Hypertension; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan

2005
Valsartan in chronic heart failure.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:3

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Drug Therapy, Combination; Female; Formularies, Hospital as Topic; Heart Failure; Humans; Liver Diseases; Male; Patient Education as Topic; Pregnancy; Randomized Controlled Trials as Topic; Renal Insufficiency; Tetrazoles; Valine; Valsartan

2005

Other Studies

9 other study(ies) available for valsartan and Pregnancy

ArticleYear
Valsartan exposure in pregnancy with resultant anhydramnios and chronic kidney disease in a late preterm infant.
    BMJ case reports, 2021, May-19, Volume: 14, Issue:5

    Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Child; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Oligohydramnios; Pregnancy; Renal Insufficiency, Chronic; Valsartan; Young Adult

2021
Polycythemia, capillary rarefaction, and focal glomerulosclerosis in two adolescents born extremely low birth weight and premature.
    Pediatric nephrology (Berlin, Germany), 2017, Volume: 32, Issue:7

    Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Antigens, CD34; Apgar Score; Biopsy; Child; Endothelial Cells; Erythropoietin; Female; Fibrosis; Glomerulosclerosis, Focal Segmental; Hemoglobins; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Kidney Glomerulus; Kidney Tubules; Male; Microvascular Rarefaction; Nephrons; Platelet Endothelial Cell Adhesion Molecule-1; Polycythemia; Pregnancy; Premature Birth; Proteinuria; Valsartan

2017
Angiotensin II receptor blocker induced fetopathy: 7 cases.
    Klinische Padiatrie, 2011, Volume: 223, Issue:1

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Apgar Score; Benzimidazoles; Biphenyl Compounds; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Hypertension, Pulmonary; Imidazoles; Infant, Newborn; Kidney; Lung; Male; Oligohydramnios; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Renal Insufficiency; Skull; Tetrazoles; Ultrasonography, Prenatal; Valine; Valsartan

2011
The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England.
    Journal of human hypertension, 2002, Volume: 16, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cohort Studies; Dizziness; Drug Monitoring; England; Female; Headache; Humans; Hypertension; Male; Middle Aged; Nausea; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Product Surveillance, Postmarketing; Tetrazoles; Valine; Valsartan

2002
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
    American journal of physiology. Cell physiology, 2006, Volume: 290, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Astrocytes; Carboxypeptidases; Cells, Cultured; Cerebellum; Female; Gene Expression Regulation; Imidazoles; Losartan; Medulla Oblongata; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents

2006
[Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Gynecologie, obstetrique & fertilite, 2007, Volume: 35, Issue:6

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Female; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan

2007
Valsartan. Just a second-line antihypertensive drug.
    Canadian family physician Medecin de famille canadien, 1999, Volume: 45

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Pregnancy; Tetrazoles; Treatment Outcome; Valine; Valsartan

1999
Angiotensin-II-receptor inhibitors in pregnancy.
    Lancet (London, England), 2001, May-19, Volume: 357, Issue:9268

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prenatal Care; Risk Assessment; Sensitivity and Specificity; Tetrazoles; Time Factors; Valine; Valsartan

2001
Fetal toxic effects and angiotensin-II-receptor antagonists.
    Lancet (London, England), 2001, Jul-21, Volume: 358, Issue:9277

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Humans; Hypertension; Losartan; Pregnancy; Pregnancy Complications, Cardiovascular; Tetrazoles; Valine; Valsartan

2001